Reuters logo
BRIEF-Tetra Bio-Pharma to file for CTA to initiate Phase 3 clinical trial on terminal cancer patients
2017年9月18日 / 下午12点46分 / 1 个月前

BRIEF-Tetra Bio-Pharma to file for CTA to initiate Phase 3 clinical trial on terminal cancer patients

Sept 18 (Reuters) - Tetra Bio Pharma Inc

* Tetra Bio-Pharma getting ready to file a Clinical Trial Application to initiate Phase 3 clinical trial on terminal cancer patients in the coming weeks

* Tetra Bio Pharma - ‍ with filing of Clinical Trial Application, co expects to be on time with previously announced schedule with development of PPP001​

* Tetra Bio Pharma Inc - ‍ restructured its investors and public relation functions to integrate them with marketing and communication functions​

* Tetra Bio Pharma Inc - ‍ Edward Miller is leaving corporation effective as of Sept 18​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below